SGX-523是一种新型有效、ATP-竞争性并高度选择性的Met（肝细胞生长因子受体）抑制剂，其IC50值为4 nM，具有抗肿瘤活性。

参考文献

[1]. Buchanan SG, et al. SH. SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo. Mol Cancer Ther. 2009 Dec;8(12):3181-90.

[2]. Infante JR, et al. Unexpected renal toxicity associated with SGX523, a small molecule inhibitor of MET. Invest New Drugs. 2013 Apr;31(2):363-9.

冰袋运输。粉末直接保存于-20℃，有效期2年。建议分装后-20℃避光保存，避免反复冻融。